Lean/normal‐weight metabolic dysfunction‐associated fatty liver disease is a risk factor for reflux esophagitis
Shuhei Fukunaga(Kurume University), Takuji Torimura(Omuta hospital), Dan Nakano(Kurume University), Tsubasa Tsutsumi(Kurume University), Ryuichi Nouno(Kumamoto Chuo Hospital), Seiya Joh, Keiichi Mitsuyama(Kurume University), Mohammed Eslam(The University of Sydney), Takumi Kawaguchi(Kurume University), Shinobu Yoshinaga, Hirohiko ABE(Kumamoto Chuo Hospital), Jacob George(University of Dundee)
Cited by 28
Related Papers
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
|Hepatology International|2020|841
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
|American Journal Of Pathology|2004|536